The competitive cost of antibiotic resistance in <em>Mycobacterium tuberculosis</em> (Publications)
Mathematical models predict that the future of the multidrug-resistant tuberculosis epidemic will depend on the fitness cost of drug resistance. We show that in laboratory-derived mutants of Mycobacte
Global phylogeography of <em>Mycobacterium tuberculosis</em> and implications for tuberculosis product development (Publications)
New tools for controlling tuberculosis are urgently needed. Despite our emerging understanding of the biogeography of Mycobacterium tuberculosis, the implications for development of new diagnostics, d
Drug repurposing in the chemotherapy of infectious diseases (Publications)
Repurposing is a universal mechanism for innovation, from the evolution of feathers to the invention of Velcro tape. Repurposing is particularly attractive for drug development, given that it costs mo